Dasatinib-Induced Chylothorax in Chronic Myeloid Leukemia
Document Type
Article
Department
Internal Medicine (East Africa)
Abstract
Pulmonary adverse events are common abnormalities associated with the use of dasatinib in chronic myeloid leukemia. We present a case of a 69-year-old man who suddenly developed a rare chylothorax pulmonary adverse event following 10 months of dasatinib treatment.
Publication (Name of Journal)
Baylor University Medical Center Proceedings
Recommended Citation
Baloch, Z. Q.,
Shabber, A. A.,
Hammad, B.,
Karar, S.
(2017). Dasatinib-Induced Chylothorax in Chronic Myeloid Leukemia. Baylor University Medical Center Proceedings, 30(1), 71-73.
Available at:
https://ecommons.aku.edu/eastafrica_fhs_mc_intern_med/305
COinS